Tevogen (TVGN) Change in Account Payables (2022 - 2026)

Tevogen Bio Holdings (TVGN) has 5 years of Change in Account Payables data on file, last reported at $458472.0 in Q1 2026.

• Quarterly Change in Account Payables rose 185.62% year-over-year to $458472.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$970147.0 (down 77.31% YoY) and the FY2025 annual result came in at -$2.0 million, down 216.52% from the prior year.
• Change in Account Payables advanced to $458472.0 in Q1 2026, from $28196.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.7 million in Q1 2024 to a low of -$1.0 million in Q3 2025.
• A 5-year average of $83194.5 and a median of $30000.0 in 2022 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 1558.28% in 2023, down 516.23% in 2023.
• Tracing TVGN's Change in Account Payables over 5 years: stood at $30000.0 in 2022, then soared by 1065.42% to $349625.0 in 2023, then plunged by 282.51% to -$638117.0 in 2024, then soared by 104.42% to $28196.0 in 2025, then surged by 1526.02% to $458472.0 in 2026.
• The last three Change in Account Payables figures came in at $458472.0 (Q1 2026), $28196.0 (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.